These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23493437)

  • 1. Comparison of in vivo Adjuvanticity of Liposomal PO CpG ODN with Liposomal PS CpG ODN: Soluble Leishmania Antigens as a Model.
    Golali E; Jaafari MR; Khamesipour A; Abbasi A; Saberi Z; Badiee A
    Iran J Basic Med Sci; 2012 Sep; 15(5):1032-45. PubMed ID: 23493437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis.
    Shargh VH; Jaafari MR; Khamesipour A; Jaafari I; Jalali SA; Abbasi A; Badiee A
    Vaccine; 2012 Jun; 30(26):3957-64. PubMed ID: 22465747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis.
    Heravi Shargh V; Jaafari MR; Khamesipour A; Jalali SA; Firouzmand H; Abbasi A; Badiee A
    Parasitol Res; 2012 Jul; 111(1):105-14. PubMed ID: 22223037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice.
    Badiee A; Jaafari MR; Samiei A; Soroush D; Khamesipour A
    Clin Vaccine Immunol; 2008 Apr; 15(4):668-74. PubMed ID: 18235040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome.
    Emami T; Rezayat SM; Khamesipour A; Madani R; Habibi G; Hojatizade M; Jaafari MR
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):324-333. PubMed ID: 29607698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
    J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble
    Hojatizade M; Badiee A; Khamesipour A; Jaafari MR
    Iran J Parasitol; 2019; 14(1):68-77. PubMed ID: 31123470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.
    Stacey KJ; Blackwell JM
    Infect Immun; 1999 Aug; 67(8):3719-26. PubMed ID: 10417129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
    Jaafari MR; Badiee A; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Vaccine; 2007 Aug; 25(32):6107-17. PubMed ID: 17629372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingomyelin Liposomes Containing Soluble Leishmania major antigens Induced Strong Th2 Immune Response in BALB/c Mice.
    Chavoshian O; Biari N; Badiee A; Khamesipour A; Abbasi A; Saberi Z; Jalali SA; Jaafari MR
    Iran J Basic Med Sci; 2013 Sep; 16(9):965-72. PubMed ID: 24171074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.
    Naseri H; Eskandari F; Jaafari MR; Khamesipour A; Abbasi A; Badiee A
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28921566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
    Firouzmand H; Badiee A; Khamesipour A; Heravi Shargh V; Alavizadeh SH; Abbasi A; Jaafari MR
    Acta Trop; 2013 Dec; 128(3):528-35. PubMed ID: 23916506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Leishmanization Using
    Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
    Front Immunol; 2020; 11():1725. PubMed ID: 33193290
    [No Abstract]   [Full Text] [Related]  

  • 14. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice.
    Mehravaran A; Rezaei Nasab M; Mirahmadi H; Sharifi I; Alijani E; Nikpoor AR; Akhtari J; Hojatizade M
    Iran J Basic Med Sci; 2019 Aug; 22(8):922-931. PubMed ID: 31579449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA.
    Kim D; Rhee JW; Kwon S; Sohn WJ; Lee Y; Kim DW; Kim DS; Kwon HJ
    Biochem Biophys Res Commun; 2009 Feb; 379(2):362-7. PubMed ID: 19103173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
    Kim D; Jung J; Lee Y; Kwon HJ
    Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Liposomal CpG ODN on the Course of L. major Infection in BALB/C Mice.
    Hejazi H; Tasbihi M; Jaafari M; Badiee A; Pestechian N; Javadi A; Khamesipour A
    Iran J Parasitol; 2010 Mar; 5(1):47-54. PubMed ID: 22347235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 agonist CpG ODN 2395 promotes the immune response against Leishmania donovani in obesity and undernutrition mice.
    He J; Huang F; Liao X; Zhang J; Wei S; Xiao Y; Zheng X; Zhu Z; Chen D; Chen J
    Acta Trop; 2023 Jun; 242():106921. PubMed ID: 37030488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis.
    Eskandari F; Talesh GA; Parooie M; Jaafari MR; Khamesipour A; Saberi Z; Abbasi A; Badiee A
    Exp Parasitol; 2014 Nov; 146():78-86. PubMed ID: 25246326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.